AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal and Metabolism, and Respiratory and Immunology.

Based in Cambridge, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

In Southeast Asia, AstraZeneca has offices in Singapore, Malaysia, the Philippines, Indonesia, Thailand and Vietnam, and is also active in Brunei, Cambodia and Myanmar. To transform the lives of our patients in the region, AstraZeneca actively partners with governments, hospitals, academia and industry partners on strengthening healthcare delivery through medical, educational and digital solutions.